Article metrics

Download PDFPDF

353 Identification of potential response predictors to maveropepimut-S (DPX-Survivac), a novel T cell activating immunotherapy, in patients with advanced recurrent ovarian cancer
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to January 2024

AbstractFullPdf
Nov 2021242010
Dec 20216003
Jan 20226207
Feb 20225204
Mar 2022230012
Apr 20227005
May 202246010
Jun 20222407
Jul 20223201
Aug 20224801
Sep 202256016
Oct 20224206
Nov 20225607
Dec 20223601
Jan 202344010
Feb 20235005
Mar 20235002
Apr 20233802
May 20232404
Jun 2023602
Jul 20231006
Aug 20232802
Sep 20232005
Oct 20231404
Nov 20231403
Dec 20233804
Jan 20244002
Total14320141